home / stock / nwbo / nwbo quote
Last: | $0.92 |
---|---|
Change Percent: | -2.78% |
Open: | $0.935 |
Close: | $0.92 |
High: | $0.94 |
Low: | $0.87 |
Volume: | 1,751,207 |
Last Trade Date Time: | 10/02/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.92 | $0.935 | $0.92 | $0.94 | $0.87 | 1,751,207 | 10-02-2023 |
$0.9097 | $0.8551 | $0.9097 | $0.93 | $0.8499 | 2,786,877 | 09-29-2023 |
$0.87 | $0.8351 | $0.87 | $0.87791 | $0.777 | 3,397,537 | 09-28-2023 |
$0.83 | $0.94 | $0.83 | $0.95 | $0.78 | 7,772,252 | 09-27-2023 |
$0.94755 | $1.04 | $0.94755 | $1.05 | $0.93 | 2,846,442 | 09-26-2023 |
$1.04 | $0.99 | $1.04 | $1.09 | $0.9501 | 3,837,568 | 09-25-2023 |
$1 | $1.01 | $1 | $1.01 | $0.8611 | 6,693,291 | 09-22-2023 |
$0.995 | $0.8675 | $0.995 | $1.01 | $0.861 | 7,748,230 | 09-21-2023 |
$0.855 | $0.843 | $0.855 | $0.8555 | $0.7951 | 4,298,988 | 09-20-2023 |
$0.825 | $0.7953 | $0.825 | $0.8293 | $0.78 | 7,169,049 | 09-19-2023 |
$0.7585 | $0.7108 | $0.7585 | $0.7625 | $0.701 | 3,456,240 | 09-18-2023 |
$0.6865 | $0.7 | $0.6865 | $0.7 | $0.68 | 1,768,702 | 09-15-2023 |
$0.6922 | $0.69 | $0.6922 | $0.71 | $0.671 | 1,327,719 | 09-14-2023 |
$0.687 | $0.6744 | $0.687 | $0.7 | $0.651 | 1,933,887 | 09-13-2023 |
$0.67 | $0.66 | $0.67 | $0.6879 | $0.605 | 1,965,740 | 09-12-2023 |
$0.641 | $0.7 | $0.641 | $0.7 | $0.6193 | 1,715,643 | 09-11-2023 |
$0.69 | $0.7002 | $0.69 | $0.7121 | $0.683 | 2,845,257 | 09-08-2023 |
$0.6875 | $0.66 | $0.6875 | $0.694 | $0.66 | 2,624,261 | 09-07-2023 |
$0.6555 | $0.6699 | $0.6555 | $0.7 | $0.65 | 2,755,046 | 09-06-2023 |
$0.645 | $0.5748 | $0.645 | $0.645 | $0.57 | 2,426,029 | 09-05-2023 |
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
LAS VEGAS, NV / ACCESSWIRE / September 25, 2023 / Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a proposed public offering of its common stock. The public offering is ...
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board PR Newswire BETHESDA, Md. , Sept. 12, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ...
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application PR Newswire BETHESDA, Md. , Aug. 29, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company ...